Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Gentilin

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Endocrinology|April 16, 2010
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line modelMaria Chiara Zatelli, Erica Gentilin, Fulvia Daffara, et al.
Frontiers in Neurology|June 2, 2020
Immune Response After Cochlear ImplantationEdi Simoni, Erica Gentilin, Mariarita Candito, et al.
The Journal of Endocrinology|July 2, 2013
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and functionErica Gentilin, Federico Tagliati, Massimo Terzolo, et al.
Molecular and Cellular Endocrinology|November 3, 2015
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cellsErica Gentilin, Carmelina Di Pasquale, Teresa Gagliano, et al.
Biochemical Pharmacology|October 21, 2015
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumorsTeresa Gagliano, Erica Gentilin, Federico Tagliati, et al.
The Journal of Clinical Endocrinology and Metabolism|March 24, 2012
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expressionMariella Minoia, Erica Gentilin, Daniela Molè, et al.
Endocrine|August 7, 2014
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cellsTeresa Gagliano, Erica Gentilin, Katiuscia Benfini, et al.
Frontiers in Endocrinology|May 23, 2015
Igf-I influences everolimus activity in medullary thyroid carcinomaErica Gentilin, Carmelina Di Pasquale, Martina Rossi, et al.
Endocrinology|March 1, 2012
Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitroDaniela Molè, Erica Gentilin, Teresa Gagliano, et al.
Endocrine-Related Cancer|May 9, 2013
mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoidsTeresa Gagliano, Mariaenrica Bellio, Erica Gentilin, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Endocrinology|April 16, 2010
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line modelMaria Chiara Zatelli, Erica Gentilin, Fulvia Daffara, et al.
Frontiers in Neurology|June 2, 2020
Immune Response After Cochlear ImplantationEdi Simoni, Erica Gentilin, Mariarita Candito, et al.
The Journal of Endocrinology|July 2, 2013
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and functionErica Gentilin, Federico Tagliati, Massimo Terzolo, et al.
Molecular and Cellular Endocrinology|November 3, 2015
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cellsErica Gentilin, Carmelina Di Pasquale, Teresa Gagliano, et al.
Biochemical Pharmacology|October 21, 2015
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumorsTeresa Gagliano, Erica Gentilin, Federico Tagliati, et al.
The Journal of Clinical Endocrinology and Metabolism|March 24, 2012
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expressionMariella Minoia, Erica Gentilin, Daniela Molè, et al.
Endocrine|August 7, 2014
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cellsTeresa Gagliano, Erica Gentilin, Katiuscia Benfini, et al.
Frontiers in Endocrinology|May 23, 2015
Igf-I influences everolimus activity in medullary thyroid carcinomaErica Gentilin, Carmelina Di Pasquale, Martina Rossi, et al.
Endocrinology|March 1, 2012
Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitroDaniela Molè, Erica Gentilin, Teresa Gagliano, et al.
Endocrine-Related Cancer|May 9, 2013
mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoidsTeresa Gagliano, Mariaenrica Bellio, Erica Gentilin, et al.
Pageof 4